跳至主要内容
临床试验/EUCTR2004-002653-31-DK
EUCTR2004-002653-31-DK进行中(未招募)1 期

CAPHI. Profylactic effect of Ca2+ sensitizer versus phosphodiesterase inhibitor infusion at CAGB patients with preoperative low ejection fraction. A prospective randomised clinical trial. - CAPHI

Odense University hospital0 个研究点目标入组 40 人开始时间: 2004年9月30日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • elective CABG patient with a preoperative ejection fraction below 35%
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • s- creatinin> 150mM
  • albumin< 35g/l
  • systolic bloodpressure <90mmHg
  • trombocyt<100x10^9
  • known coagulopati
  • p- kalium<3 mmol/l
  • heart frekvens >100/s
  • other kind of heart surgery in same operation
  • preoperative intraaortic balloon pump
  • preoperativ need of inotropi

研究者

相似试验